Meta-Analysis on the Association Between the TF Gene rs1049296 and AD
Authors:
Open Access
- 23 September 2013
- journal article
- research article
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 40 (5) , 691-697
Abstract
Polymorphisms of genes participating in iron transportation have been associated with Alzheimer's disease (AD) risk. The association between transferrin (TF) gene rs1049296 (P570S) polymorphism and AD is controversial. We performed meta analysis on data from 19 studies with 6310 cases and 13661 controls to reexamine the association between the TF gene rs1049296 polymorphism and AD. We applied a fixed-effects model to combine the odds ratio (OR) and 95% confidence intervals (95% CI). Egger's test was carried out to evaluate the potential publication bias. The overall ORs with 95% CIs showed statistical association between the TF gene rs1049296 polymorphism and the risk of AD in the allele contrast, the recessive model and the dominant model for allele C2 (fixed-effects pooled OR 1.11; 95% CI 1.05 to 1.17, pooled OR 1.13; 95% CI 1.06 to 1.21, and pooled OR 1.23; 95% CI 1.03 to 1.47, respectively). In the contrast of C2C2+C2C1 vs C1C1, large heterogeneity among the Asian subgroup (p=0.041, I2= 68.6%) was observed but not among the overall population (p = 0.184, I2= 22.4%). No publication bias was observed. The present meta analysis demonstrated that TF gene rs1049296 polymorphism is a genetic determinant of AD.Keywords
This publication has 48 references indexed in Scilit:
- Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's diseaseAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2010
- Ternary Complexes of Iron, Amyloid-β, and Nitrilotriacetic Acid: Binding Affinities, Redox Properties, and Relevance to Iron-Induced Oxidative Stress in Alzheimer’s DiseaseBiochemistry, 2009
- Assessment of Alzheimer’s disease case–control associations using family-based methodsneurogenetics, 2008
- Therapeutics for Alzheimer's Disease Based on the Metal HypothesisNeurotherapeutics, 2008
- GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 CarriersNeuron, 2007
- Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene databaseNature Genetics, 2007
- Analysis of the effect of aluminum in drinking water and transferrin C2 allele on Alzheimer's diseaseEuropean Journal of Neurology, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984